German dose form plant ok'd

Just three minor Form 483 observations followed a pre-approval inspection of New Jersey-based Catalent Pharma's integrated dose form development, manufacturing and packaging facility in Schorndorf, Germany. The facility provides formulation and development services as well as clinical and commercial manufacturing for oral tablets and capsules, powders and other dosage forms. Release

Suggested Articles

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.